Key Takeaways: How to Fix Clinical Trial Recruitment Bottlenecks More than 80% of clinical trials face delays due to patient recruitment challenges, making proactive planning essential for trial success. Structural barriers like geographic dispersion and strict eligibility criteria disproportionately impact enrollment at global sites. Underrepresented populations participate in trials at rates less than half their representation in the general population. Antidote's precision recruitment approach helps sponsors reach patients through data-driven targeting and thorough prescreening before site referral. Decentralized trial elements and patient-centric designs can reduce dropout rates while improving enrollment diversity across multiple regions. What Are Clinical Trial Recruitment Bottlenecks? Clinical trial recruitment bottlenecks are points in the enrollment process where patient flow slows down or stops entirely. These bottlenecks can occur at multiple stages, from initial patient identification through screening, consent, and randomization.